Advanced

Abemaciclib & Aromatase Inhibitor Locally Advanced & Metastatic Breast Cancer Protocol V1.0

Abemaciclib & Fulvestrant Locally Advanced and Metastatic Breast Cancer Protocol V1.2

Albumin Paclitaxel (Abraxane) Protocol V1.0

ALPELISIB (Piqray®) and FULVESTRANT Locally Advanced and Metastatic Breast Cancer Protocol V1.0

Atezolizumab/ Paclitaxel Albumin (Abraxane) Triple Negative Breast Cancer, PDL1 Positive Protocol V1.1

Capecitabine Breast Cancer Protocol V1.2

Docetaxel & Capecitabine Advanced Breast Cancer Protocol V1.1

Docetaxel, Trastuzumab, Pertuzumab with Paclitaxel Alternative Advanced Breast Cancer Protocol V1.1

Doxorubicin Weekly Advanced Breast Cancer Protocol V1.0

EC (Epirubicin Cyclophosphamide) Advanced Breast Cancer Regimen Protocol V1.0

Enhertu (Trastuzumab Deruxtecan) HER2 Positive Advanced Breast Cancer Protocol V1.0

Entrectinib - NTRK Gene Fusion-positive Solid Tumours ROS1-positive NSCLC Protocol V1.1

Epirubicin Weekly Advanced Breast Cancer Protocol V1.0

Eribulin Advanced Breast Cancer Protocol V2.0

Everolimus & Exemestane Protocol V1.0

Kadcyla (Trastuzumab Emtansine) Early Breast Cancer and Locally Advanced or Metastatic Breast Cancer Protocol V1.2

Larotrectinib NTRK Gene Fusion-positive Solid Tumours Protocol V1.0

Neratinib and Capecitabine Early Access Program (EAP) Metastatic Breast Cancer Protocol V1.1

Paclitaxel & Gemcitabine Advanced Breast Cancer Protocol V1.1

Paclitaxel Weekly Advanced Breast Cancer Protocol V1.1

Palbociclib Protocol V1.1

Palbociclib & Fulvestrant Protocol V1.1

Ribociclib Protocol V1.1

Ribociclib & Fulvestrant Locally Advanced or Metastatic Breast Cancer Protocol V1.1

Talazoparib Breast Cancer with BRCA1/2 Mutations Protocol V1.0

Trastuzumab Subcutaneous Advanced Breast Cancer Protocol V1.0

trastuzumab (subcutaneous) protocol

Vinorelbine Advanced Breast Cancer Protocol V1.1